SEO URLwww.firestrike.ai/deals/orna-therapeutics-lilly-acquisition-2026-1
acquisitionAnnounced · Feb 12, 2026BiotechnologySource · CredibleArticle · Factual
Lilly acquires Orna Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.4B
Target
Orna Therapeutics
Cambridge, Massachusetts
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Orna Therapeutics. Reported deal value: $2.4B. Status: Announced. Sector: Biotechnology. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-12. Figures and status may change as filings and press coverage update.
Eli Lilly and Company to Acquire Orna Therapeutics in $2.4B Deal to Expand RNA Pipeline On February 9, Eli Lilly and Company announced an agreement to acquire Orna Therapeutics in a transaction valued at up to $2.4 billion in cash
Deal timeline
Announced
Feb 12, 2026 · finance.yahoo.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $2.4B. Figures and status may change as sources update.
Sources: finance.yahoo.com · Primary article · FireStrike proprietary index